Healthcare costs could rise by nearly 10% in 2027

Employers are poised to face a near‑10% rise in healthcare costs by 2027, according to a new Aon report that tracks employer‑borne medical spending. The study, which marks the fourth straight year that cost growth has approached double‑digit levels, finds that employer contributions—currently covering more than 80% of the total burden—are set to climb from a 3.7% increase in 2022 to an 8.8% jump by 2026, with the upward trajectory expected to continue into 2027. Aon’s North America health solutions leader, Mike Pasterick, warned that such inflation “becomes much more than a budgeting challenge,” influencing decisions on benefits strategy, employee affordability, and broader workforce and financial planning. The report also highlights that employees will bear a larger share of expenses as firms adjust plan designs.

The surge in spending is driven by several interrelated factors, chief among them the growing prevalence of chronic conditions that generate high‑cost claims. In addition, the expanding use of specialty pharmaceuticals—particularly GLP‑1 therapies—has amplified prescription drug expenditures, forcing employers to balance access to cutting‑edge treatments against overall affordability and long‑term sustainability. Aon’s chief actuary, Debbie Ashford, emphasized that organizations that can proactively identify emerging risks and act before costs spiral will be best positioned for the future. Complementary data from Mercer indicate that nearly half of U.S. employers with 500 or more workers plan to shift more cost responsibility onto employees for 2027 plans, while a survey by the National Alliance of Healthcare Purchaser Coalitions shows 83% of employers expect to trade off wage and salary increases to offset rising health expenses.

The implications of these trends extend beyond budgeting, affecting talent attraction, retention, and overall workforce morale. As employers grapple with higher premiums and increased employee contributions, they may need to redesign benefit packages, explore cost‑containment strategies, and potentially reconsider compensation structures. The heightened financial pressure could also spur greater adoption of alternative payment models or wellness initiatives aimed at reducing chronic disease prevalence. While the report focuses on employer costs, the broader economic impact includes potential shifts in consumer spending and labor market dynamics as workers adjust to higher out‑of‑pocket health expenses.

⚡ Effects Interpreter